Tadalafil in Treating Patients Undergoing Surgery for Cancer of the Oral Cavity or Oropharynx
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Biological therapies, such as tadalafil, may stimulate the immune system in
different ways and stop tumor cells from growing.
PURPOSE: This randomized clinical trial is studying how well tadalafil works in treating
patients who are undergoing surgery for cancer of the oral cavity or oropharynx.